Mengwei Yang

机构：Chinese Academy of Medical Sciences & Peking Union Medical College · ORCID：0009-0000-0652-6212

发表论文 13 篇 · 总被引 69 次 · h-index 5

代表论文

• Integrative analyses of bulk and single-cell RNA-seq identified cancer-associated fibroblasts-related signature as a prognostic factor for immunotherapy in NSCLC (2023 · Cancer Immunology Immunotherapy · 被引 27)
• JAK3 A573V and JAK3 M511I mutations in peripheral T-cell lymphoma mediating resistance to anti-PD-1 therapy through the STAT3/PD-L1 pathway (2025 · Journal for ImmunoTherapy of Cancer · 被引 13)
• Spatial analyses revealed S100P + TFF1 + tumor cells in spread through air spaces samples correlated with undesirable therapy response in non-small cell lung cancer (2024 · Journal of Translational Medicine · 被引 8)
• Longitudinal plasma proteomic profiling of EML4-ALK positive lung cancer receiving ALK-TKIs therapy (2024 · Lung Cancer · 被引 8)
• Multiomics and Single-Cell Insights Reveal a Lysophosphatidic Acid–Mediated Resistant Mechanism to Third-generation EGFR-TKI in Non–Small Cell Lung Cancer (2025 · Clinical Cancer Research · 被引 6)
• A Novel IgG–IgM Autoantibody Panel Enhances Detection of Early-stage Lung Adenocarcinoma from Benign Nodules (2024 · Genomics Proteomics & Bioinformatics · 被引 4)